Biotech ETF (BBC) Touches a New 52-Week High
For investors seeking momentum, Virtus Biotech Clinical Trials ETF BBC is probably on the radar now. The fund just hit a 52-week high and gained 2.2% from its 52-week low price of $51.24 per share.But are there more gains in store for this ETF? Let’s take a quick look at the fund and its near-term…
For investors seeking momentum, Virtus Biotech Clinical Trials ETF BBC is probably on the radar now. The fund just hit a 52-week high and gained 2.2% from its 52-week low price of $51.24 per share.But are there more gains in store for this ETF? Let’s take a quick look at the fund and its near-term…
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
